Ideal Option Secures Minority Investment by BlueCross BlueShield Venture Partners

Industry News   •   February 6, 2019

NEW YORK–(BUSINESS WIRE)–Ideal Option, a leading provider of Medication-Assisted Treatment (MAT) and behavioral counseling services for individuals suffering from Opioid Use Disorder (OUD), announced today a strategic minority investment by BlueCross BlueShield Venture Partners (“BCBSVP”). BCBSVP invests on behalf of 33 BlueCross BlueShield entities in healthcare companies of strategic relevance to BlueCross BlueShield Plans.

“The mission of the Company is aligned to the mission of many of our Blue Plan partners. BCBS Venture Partners is excited to partner with Varsity Health Partners to amplify the reach of Ideal Option and create a national, high-quality network of treatment providers focused on addressing the opioid crisis.”

“The team at Ideal Option has expanded access to MAT to some of the most underserved communities in the country,” said Binoy Bhansali, Vice President Healthcare, Sandbox Industries, on behalf of BlueCross BlueShield Venture Partners, and Ideal Option Board Member. “The mission of the Company is aligned to the mission of many of our Blue Plan partners. BCBS Venture Partners is excited to partner with Varsity Health Partners to amplify the reach of Ideal Option and create a national, high-quality network of treatment providers focused on addressing the opioid crisis.”

In September 2018, Ideal Option received a growth investment from Varsity Healthcare Partners to expand Ideal Option’s commitment of increasing affordable and evidence-based treatment access to communities impacted by the national opioid epidemic. The strategic investment by BCBSVP underlines the importance of Ideal Option to all constituents – patients, providers, payors and communities across the country.

This article originally appeared in an article in BusinessWire.

2019-02-06T18:18:26+00:00 February 6th, 2019|